Deep immunological imprinting due to the ancestral spike in the current bivalent COVID-19 vaccine
2023 · Cell Reports Medicine · 72 citations
https://doi.org/10.1016/j.xcrm.2023.101258
A
Anthony Raymond Tam
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
143
Papers
15.6K
Citations
38
h-index
73
i10-index
Anthony Raymond Tam is an academic researcher from University of Hong Kong. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Chronic Obstructive Pulmonary Disease (COPD) Research. The author has an h-index of 38, co-authored 122 publications.
ORCID: 0000-0001-8821-780XPapers by this author
worksAutocrine IL-6/STAT3 signaling aids development of acquired drug resistance in Group 3 medulloblastoma
2020 · Cell Death and Disease · 44 citations
https://doi.org/10.1038/s41419-020-03241-y
The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum
2021 · EBioMedicine · 43 citations
https://doi.org/10.1016/j.ebiom.2021.103544
Phylogenomic analysis of COVID-19 summer and winter outbreaks in Hong Kong: An observational study
2021 · The Lancet Regional Health - Western Pacific · 33 citations
https://doi.org/10.1016/j.lanwpc.2021.100130
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines
2022 · EBioMedicine · 30 citations
https://doi.org/10.1016/j.ebiom.2022.103986
A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors
2023 · Endocrine · 21 citations
https://doi.org/10.1007/s12020-022-03281-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat